These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17011465)

  • 1. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
    Sanguineti G; Endres EJ; Gunn BG; Parker B
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):931-8. PubMed ID: 17011465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
    Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
    Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
    Hunt MA; Jackson A; Narayana A; Lee N
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer.
    Breen SL; Craig T; Bayley A; O'Sullivan B; Kim J; Jaffray D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):321-5. PubMed ID: 16377418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT.
    Clivio A; Fogliata A; Franzetti-Pellanda A; Nicolini G; Vanetti E; Wyttenbach R; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):118-24. PubMed ID: 19181409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
    Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-sparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: a planning study.
    Saibishkumar EP; MacKenzie MA; Severin D; Mihai A; Hanson J; Daly H; Fallone G; Parliament MB; Abdulkarim BS
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):485-91. PubMed ID: 17881140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
    Knab B; Rash C; Farrey K; Jani AB
    Med Dosim; 2006; 31(4):292-7. PubMed ID: 17134669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation planning comparison for superficial tissue avoidance in radiotherapy for soft tissue sarcoma of the lower extremity.
    Griffin AM; Euler CI; Sharpe MB; Ferguson PC; Wunder JS; Bell RS; Chung PW; Catton CN; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):847-56. PubMed ID: 17161553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.